Literature DB >> 49141

In vivo uptake and metabolism of 3-h-5alpha-androstane-3alpha,17beta-diol and of 3-h-5alpha-androstane-3beta,17beta-diol by human prostatic hypertrophy.

H J Horst, M Dennis, J Kaufmann, K D Voigt.   

Abstract

Tritiated 5alpha-androstane-3alpha,17beta-diol (3alpha-diol) and 5alpha-androstane-3beta,17beta-diol (3beta-diol) respectively were administered to patients with benign prostatic hypertrophy (bph) undergoing prostatectomy. In prostate and skeletal muscle homogenates and in plasma the total radioactivity content as well as the formation of metabolites were measured. Histological examination of each ectomized prostate was performed to evaluate the cellular composition of the tissue. After 3alpha-diol injection, a higher uptake of radioactivity in the prostate was obtained than after 3beta-diol. Within 30 min the 3alpha-isomer was very efficiently converted to 5alpha-DHT, while most of the 3beta-isomer remained unchanged. There was, however, also after administration of the 3beta-diol a substantial biconversion to 5alpha-DHT as has been confirmed by recrystallization to constant specific radioactivity. Only after 3beta-diol epiandrosterone was detected in small but significant amounts. 3alpha-diol administration resulted in distinct concentrations of 3beta-diol, whereas the conversion of 3beta-diol to the 3alpha-isomer was insignificant. When comparing the histological composition of the prostatic tissue with the accumulation of radioactivity and the formation of metabolites only a weak correlation between glandular structure and radioactivity uptake after 3alpha-diol administration could be revealed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 49141

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  7 in total

Review 1.  Identification of the molecular switch that regulates access of 5alpha-DHT to the androgen receptor.

Authors:  Trevor M Penning; David R Bauman; Yi Jin; Tea Lanisik Rizner
Journal:  Mol Cell Endocrinol       Date:  2007-01-16       Impact factor: 4.102

Review 2.  Regulation of 17β-hydroxysteroid dehydrogenases in cancer: regulating steroid receptor at pre-receptor stage.

Authors:  Mirja Rotinen; Joaquín Villar; Ignacio Encío
Journal:  J Physiol Biochem       Date:  2012-02-29       Impact factor: 4.158

Review 3.  New frontiers in androgen biosynthesis and metabolism.

Authors:  Trevor M Penning
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

4.  Transcriptional regulation of type 11 17β-hydroxysteroid dehydrogenase expression in prostate cancer cells.

Authors:  Mirja Rotinen; Joaquín Villar; Jon Celay; Irantzu Serrano; Vicente Notario; Ignacio Encío
Journal:  Mol Cell Endocrinol       Date:  2011-04-28       Impact factor: 4.102

Review 5.  Pre-receptor regulation of the androgen receptor.

Authors:  Trevor M Penning; Yi Jin; Tea Lanisnik Rizner; David R Bauman
Journal:  Mol Cell Endocrinol       Date:  2007-10-22       Impact factor: 4.102

6.  Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer.

Authors:  Fumio Ishizaki; Tsutomu Nishiyama; Takashi Kawasaki; Yoshimichi Miyashiro; Noboru Hara; Itsuhiro Takizawa; Makoto Naito; Kota Takahashi
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

7.  Dihydrotestosterone synthesis pathways from inactive androgen 5α-androstane-3β,17β-diol in prostate cancer cells: Inhibition of intratumoural 3β-hydroxysteroid dehydrogenase activities by abiraterone.

Authors:  Takashi Ando; Tsutomu Nishiyama; Itsuhiro Takizawa; Fumio Ishizaki; Yoshimichi Miyashiro; Keisuke Takeda; Noboru Hara; Yoshihiko Tomita
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.